vs
FOSTER L B CO（FSTR）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
FOSTER L B CO的季度营收约是Vericel Corp的1.7倍（$160.4M vs $92.9M），Vericel Corp净利率更高（25.0% vs 1.5%，领先23.5%），FOSTER L B CO同比增速更快（25.1% vs 23.3%），FOSTER L B CO自由现金流更多（$19.8M vs $12.8M），过去两年Vericel Corp的营收复合增速更高（34.6% vs 13.6%）
Foster L B Co.是一家总部位于美国的专业工业制造企业，主要生产销售工程通道产品、建筑组件及铁路基础设施用品，服务覆盖北美及部分全球地区的商业建筑、交通和工业领域客户。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
FSTR vs VCEL — 直观对比
营收规模更大
FSTR
是对方的1.7倍
$92.9M
营收增速更快
FSTR
高出1.8%
23.3%
净利率更高
VCEL
高出23.5%
1.5%
自由现金流更多
FSTR
多$7.0M
$12.8M
两年增速更快
VCEL
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $160.4M | $92.9M |
| 净利润 | $2.4M | $23.2M |
| 毛利率 | 19.7% | 78.7% |
| 营业利润率 | 4.9% | 24.1% |
| 净利率 | 1.5% | 25.0% |
| 营收同比 | 25.1% | 23.3% |
| 净利润同比 | 1098.3% | 17.3% |
| 每股收益（稀释后） | $0.22 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSTRVCEL
| Q4 25 | $160.4M | $92.9M | ||
| Q3 25 | $138.3M | $67.5M | ||
| Q2 25 | $143.6M | $63.2M | ||
| Q1 25 | $97.8M | $52.6M | ||
| Q4 24 | $128.2M | $75.4M | ||
| Q3 24 | $137.5M | $57.9M | ||
| Q2 24 | $140.8M | $52.7M | ||
| Q1 24 | $124.3M | $51.3M |
净利润FSTRVCEL
| Q4 25 | $2.4M | $23.2M | ||
| Q3 25 | $4.4M | $5.1M | ||
| Q2 25 | $2.9M | $-553.0K | ||
| Q1 25 | $-2.1M | $-11.2M | ||
| Q4 24 | $-242.0K | $19.8M | ||
| Q3 24 | $35.9M | $-901.0K | ||
| Q2 24 | $2.8M | $-4.7M | ||
| Q1 24 | $4.4M | $-3.9M |
毛利率FSTRVCEL
| Q4 25 | 19.7% | 78.7% | ||
| Q3 25 | 22.5% | 73.5% | ||
| Q2 25 | 21.5% | 73.7% | ||
| Q1 25 | 20.6% | 69.0% | ||
| Q4 24 | 22.3% | 77.6% | ||
| Q3 24 | 23.8% | 71.9% | ||
| Q2 24 | 21.7% | 69.5% | ||
| Q1 24 | 21.1% | 68.9% |
营业利润率FSTRVCEL
| Q4 25 | 4.9% | 24.1% | ||
| Q3 25 | 6.0% | 5.1% | ||
| Q2 25 | 5.3% | -3.2% | ||
| Q1 25 | -2.0% | -24.3% | ||
| Q4 24 | 2.4% | 24.5% | ||
| Q3 24 | 5.3% | -4.3% | ||
| Q2 24 | 3.2% | -11.5% | ||
| Q1 24 | 4.5% | -10.7% |
净利率FSTRVCEL
| Q4 25 | 1.5% | 25.0% | ||
| Q3 25 | 3.1% | 7.5% | ||
| Q2 25 | 2.0% | -0.9% | ||
| Q1 25 | -2.2% | -21.4% | ||
| Q4 24 | -0.2% | 26.3% | ||
| Q3 24 | 26.1% | -1.6% | ||
| Q2 24 | 2.0% | -8.9% | ||
| Q1 24 | 3.6% | -7.5% |
每股收益（稀释后）FSTRVCEL
| Q4 25 | $0.22 | $0.46 | ||
| Q3 25 | $0.40 | $0.10 | ||
| Q2 25 | $0.27 | $-0.01 | ||
| Q1 25 | $-0.20 | $-0.23 | ||
| Q4 24 | $-0.04 | $0.40 | ||
| Q3 24 | $3.27 | $-0.02 | ||
| Q2 24 | $0.26 | $-0.10 | ||
| Q1 24 | $0.40 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $137.5M |
| 总债务越低越好 | $42.6M | — |
| 股东权益账面价值 | $175.3M | $354.6M |
| 总资产 | $330.4M | $488.0M |
| 负债/权益比越低杠杆越低 | 0.24× | — |
8季度趋势，按日历期对齐
现金及短期投资FSTRVCEL
| Q4 25 | $4.3M | $137.5M | ||
| Q3 25 | $3.4M | $135.4M | ||
| Q2 25 | $4.2M | $116.9M | ||
| Q1 25 | $2.6M | $112.9M | ||
| Q4 24 | $2.5M | $116.2M | ||
| Q3 24 | $3.1M | $101.7M | ||
| Q2 24 | $4.0M | $102.5M | ||
| Q1 24 | $3.1M | $110.6M |
总债务FSTRVCEL
| Q4 25 | $42.6M | — | ||
| Q3 25 | $58.6M | — | ||
| Q2 25 | $81.4M | — | ||
| Q1 25 | $82.3M | — | ||
| Q4 24 | $46.8M | — | ||
| Q3 24 | $68.4M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $77.9M | — |
股东权益FSTRVCEL
| Q4 25 | $175.3M | $354.6M | ||
| Q3 25 | $174.8M | $321.9M | ||
| Q2 25 | $174.4M | $306.8M | ||
| Q1 25 | $170.8M | $295.5M | ||
| Q4 24 | $178.3M | $292.0M | ||
| Q3 24 | $181.9M | $257.5M | ||
| Q2 24 | $147.1M | $243.0M | ||
| Q1 24 | $144.6M | $233.9M |
总资产FSTRVCEL
| Q4 25 | $330.4M | $488.0M | ||
| Q3 25 | $333.9M | $453.3M | ||
| Q2 25 | $349.9M | $435.6M | ||
| Q1 25 | $342.8M | $424.6M | ||
| Q4 24 | $334.6M | $432.7M | ||
| Q3 24 | $344.5M | $390.4M | ||
| Q2 24 | $333.3M | $376.8M | ||
| Q1 24 | $326.4M | $356.7M |
负债/权益比FSTRVCEL
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.2M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $19.8M | $12.8M |
| 自由现金流率自由现金流/营收 | 12.3% | 13.8% |
| 资本支出强度资本支出/营收 | 1.5% | 2.4% |
| 现金转化率经营现金流/净利润 | 9.18× | 0.65× |
| 过去12个月自由现金流最近4个季度 | $25.2M | $24.7M |
8季度趋势，按日历期对齐
经营现金流FSTRVCEL
| Q4 25 | $22.2M | $15.0M | ||
| Q3 25 | $29.2M | $22.1M | ||
| Q2 25 | $10.4M | $8.2M | ||
| Q1 25 | $-26.1M | $6.6M | ||
| Q4 24 | $24.3M | $22.2M | ||
| Q3 24 | $24.7M | $10.2M | ||
| Q2 24 | $-5.0M | $18.5M | ||
| Q1 24 | $-21.4M | $7.2M |
自由现金流FSTRVCEL
| Q4 25 | $19.8M | $12.8M | ||
| Q3 25 | $26.4M | $19.5M | ||
| Q2 25 | $7.7M | $81.0K | ||
| Q1 25 | $-28.7M | $-7.6M | ||
| Q4 24 | $22.3M | $8.5M | ||
| Q3 24 | $21.7M | $-9.2M | ||
| Q2 24 | $-7.0M | $1.8M | ||
| Q1 24 | $-24.2M | $-6.8M |
自由现金流率FSTRVCEL
| Q4 25 | 12.3% | 13.8% | ||
| Q3 25 | 19.1% | 28.8% | ||
| Q2 25 | 5.4% | 0.1% | ||
| Q1 25 | -29.4% | -14.5% | ||
| Q4 24 | 17.4% | 11.2% | ||
| Q3 24 | 15.8% | -15.9% | ||
| Q2 24 | -5.0% | 3.4% | ||
| Q1 24 | -19.4% | -13.3% |
资本支出强度FSTRVCEL
| Q4 25 | 1.5% | 2.4% | ||
| Q3 25 | 2.0% | 3.9% | ||
| Q2 25 | 1.9% | 12.9% | ||
| Q1 25 | 2.6% | 27.0% | ||
| Q4 24 | 1.5% | 18.3% | ||
| Q3 24 | 2.2% | 33.5% | ||
| Q2 24 | 1.5% | 31.8% | ||
| Q1 24 | 2.2% | 27.3% |
现金转化率FSTRVCEL
| Q4 25 | 9.18× | 0.65× | ||
| Q3 25 | 6.70× | 4.35× | ||
| Q2 25 | 3.61× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | -1.74× | — | ||
| Q1 24 | -4.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSTR
| Rail Technologies And Services Segment | $98.0M | 61% |
| Over Time Output Method | $26.3M | 16% |
| Services | $19.4M | 12% |
| Rail Technologies Products | $10.0M | 6% |
| Over Time Input Method | $8.3M | 5% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
